Skip to main content

Table 2 Relative risks used in the model

From: Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings

Comparison

Point estimate

Low

High

RR misoprostol vs oxytocin (Tunçalp [14])

PPH

1.43

1.34

1.52

Severe PPH

1.36

1.17

1.58

Additional uterotonics

1.35

1.1

1.66

Blood transfusion

0.77

0.59

1.02

Shivering

2.94

2.35

3.67

Fever

6.77

5.55

8.27

RR misoprostol vs placebo (Tunçalp [14])

PPH

0.77

0.6

0.99

Severe PPH

0.91

0.51

1.63

Additional uterotonics

0.86

0.66

1.13

Blood transfusion

0.24

0.06

0.94

Shivering

3.01

2.68

3.39

Fever

5.39

3.78

7.69

RR misoprostol vs placebo alternative values (Hundley [23])

PPH

0.58

0.38

0.87

Severe PPH

0.2

0.04

0.91

Additional uterotonics

0.34

0.16

0.73

Blood transfusion

0.16

0.07

0.38

Shivering

2.18

1

4.72

Fever

1.4

0.16

12.09

  1. Abbreviations: RR relative risk, PPH postpartum haemorrhage. Low values are the lower 95 % confidence limit; High values are the upper 95 % confidence limit from the relevant review